Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.

van de Winkel A, Menke V, Capello A, Moons LM, Pot RG, van Dekken H, Siersema PD, Kusters JG, van der Laan LJ, Kuipers EJ.

BMC Gastroenterol. 2011 Oct 6;11:108. doi: 10.1186/1471-230X-11-108.

PMID:
21977915
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inflammation and Barrett's carcinogenesis.

Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A.

Pathol Res Pract. 2012 May 15;208(5):269-80. doi: 10.1016/j.prp.2012.03.007. Epub 2012 Apr 27. Review.

PMID:
22541897
[PubMed - indexed for MEDLINE]
3.

[Carcinogenesis of Barrett's esophagus].

Endo T, Sugawara N, Shinomura Y.

Nihon Rinsho. 2005 Aug;63(8):1357-61. Review. Japanese.

PMID:
16101221
[PubMed - indexed for MEDLINE]
4.

Molecular targets for treatment of Barrett's esophagus.

Feagins LA, Souza RF.

Dis Esophagus. 2005;18(2):75-86. Review.

PMID:
16053481
[PubMed - indexed for MEDLINE]
5.

Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB.

Dis Esophagus. 2009;22(7):571-87. doi: 10.1111/j.1442-2050.2009.00947.x. Epub 2009 Feb 13. Review.

PMID:
19222528
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Molecular markers and staging of early esophageal cancer.

Hosch SB, Stoecklein NH, Izbicki JR.

Langenbecks Arch Surg. 2003 Apr;388(2):77-82. Epub 2003 Feb 20. Review.

PMID:
12712339
[PubMed - indexed for MEDLINE]
7.

[Molecular biological review of esophageal cancer].

Yokobori T, Kuwano H.

Kyobu Geka. 2013 Jan;66(1):73-84. Review. Japanese.

PMID:
23985408
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk